Trial Condition(s):
Iloprost therapy in patients with critical limb ischemia
Monitoring efficacy and safety aspects of iv. iloprost therapy of patients with critical limb ischemia by recording clinical parameters.
- Patients who fulfill the internationally defined criteria of critical limb ischemia; - Patients who are not eligible for vascular surgery or angioplasty interventions and - Patients who are treated with iloprost infusion. - The treating physician has decided iloprost treatment before study enrollment.
- Exclusion criteria are in accordance with the Summary of Product Characteristics of Ilomedin.
Locations | Status | ||
---|---|---|---|
Locations Investigative Site Many locations, Hungary | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
Iloprost therapy in patients with critical limb ischemia: evaluation of efficacy and safety
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1